[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
about
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
P2860
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@ast
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@en
type
label
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@ast
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@en
prefLabel
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@ast
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
@en
P2093
P2860
P50
P356
P1476
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
@en
P2093
Angela Venetucci
Angela Zupa
Antonio Nappi
Francesco Barbato
Giovanni Storto
Giulia Vita
Michele Di Cosola
Rosj Gallicchio
P2860
P304
P356
10.1515/RAON-2015-0043
P577
2015-11-27T00:00:00Z